Farxiga
dapagliflozin
SGLT2 inhibitor
Prescription requiredFarxiga vs Jardiance
Understand reviewed ingredients, approved uses, formulations and pharmacy acquisition benchmarks.
Jardiance
empagliflozin
SGLT2 inhibitor
Prescription requiredShared ingredients, classes or uses do not establish interchangeability or identical eligibility.
The key differences
Active ingredients
Farxiga contains dapagliflozin. Jardiance contains empagliflozin. A shared ingredient does not establish interchangeability.
Same reviewed class
Class membership does not establish clinical alternatives.
Approved uses and eligibility
The reviewed uses and their qualifications differ. Shared use concepts do not mean identical eligibility.
How they are taken
Farxiga: tablet, once daily. Jardiance: tablet, once daily. Routine frequency does not describe dose or titration.
Pharmacy acquisition benchmarks
Historical NADAC trends are available within individual products. They are not retail or patient prices and cannot rank these medicines by cost.
At a glance
Active ingredient
Farxigadapagliflozin
Jardianceempagliflozin
Medication class
FarxigaSGLT2 inhibitor
JardianceSGLT2 inhibitor
Prescription status
FarxigaPrescription required
JardiancePrescription required
This comparison provides factual information and does not recommend a treatment. Treatment decisions belong with a qualified healthcare professional.
This snapshot does not assess complete contraindications, interactions or adverse effects.